The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Insomnia Medication Market Research Report 2025

Global Insomnia Medication Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1978332

No of Pages : 97

Ask Your Query
Synopsis
The global Insomnia Medication market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Medication.
Report Scope
The Insomnia Medication market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Segment by Type
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segment by Application
Adults
Kids
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insomnia Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Insomnia Medication Market Overview
1.1 Product Overview and Scope of Insomnia Medication
1.2 Insomnia Medication Segment by Type
1.2.1 Global Insomnia Medication Market Value Comparison by Type (2024-2030)
1.2.2 Nonbenzodiazepine Receptor Agonists
1.2.3 Benzodiazepine Receptor Agonists
1.2.4 The Selective Melatonin Receptor Agonist Ramelteon
1.2.5 Sedating Antidepressants
1.3 Insomnia Medication Segment by Application
1.3.1 Global Insomnia Medication Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Kids
1.4 Global Insomnia Medication Market Size Estimates and Forecasts
1.4.1 Global Insomnia Medication Revenue 2019-2030
1.4.2 Global Insomnia Medication Sales 2019-2030
1.4.3 Global Insomnia Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insomnia Medication Market Competition by Manufacturers
2.1 Global Insomnia Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insomnia Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insomnia Medication Average Price by Manufacturers (2019-2024)
2.4 Global Insomnia Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insomnia Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insomnia Medication, Product Type & Application
2.7 Insomnia Medication Market Competitive Situation and Trends
2.7.1 Insomnia Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insomnia Medication Players Market Share by Revenue
2.7.3 Global Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insomnia Medication Retrospective Market Scenario by Region
3.1 Global Insomnia Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insomnia Medication Global Insomnia Medication Sales by Region: 2019-2030
3.2.1 Global Insomnia Medication Sales by Region: 2019-2024
3.2.2 Global Insomnia Medication Sales by Region: 2025-2030
3.3 Global Insomnia Medication Global Insomnia Medication Revenue by Region: 2019-2030
3.3.1 Global Insomnia Medication Revenue by Region: 2019-2024
3.3.2 Global Insomnia Medication Revenue by Region: 2025-2030
3.4 North America Insomnia Medication Market Facts & Figures by Country
3.4.1 North America Insomnia Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insomnia Medication Sales by Country (2019-2030)
3.4.3 North America Insomnia Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insomnia Medication Market Facts & Figures by Country
3.5.1 Europe Insomnia Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insomnia Medication Sales by Country (2019-2030)
3.5.3 Europe Insomnia Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insomnia Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Insomnia Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insomnia Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Insomnia Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insomnia Medication Market Facts & Figures by Country
3.7.1 Latin America Insomnia Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insomnia Medication Sales by Country (2019-2030)
3.7.3 Latin America Insomnia Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insomnia Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Insomnia Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insomnia Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insomnia Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insomnia Medication Sales by Type (2019-2030)
4.1.1 Global Insomnia Medication Sales by Type (2019-2024)
4.1.2 Global Insomnia Medication Sales by Type (2025-2030)
4.1.3 Global Insomnia Medication Sales Market Share by Type (2019-2030)
4.2 Global Insomnia Medication Revenue by Type (2019-2030)
4.2.1 Global Insomnia Medication Revenue by Type (2019-2024)
4.2.2 Global Insomnia Medication Revenue by Type (2025-2030)
4.2.3 Global Insomnia Medication Revenue Market Share by Type (2019-2030)
4.3 Global Insomnia Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insomnia Medication Sales by Application (2019-2030)
5.1.1 Global Insomnia Medication Sales by Application (2019-2024)
5.1.2 Global Insomnia Medication Sales by Application (2025-2030)
5.1.3 Global Insomnia Medication Sales Market Share by Application (2019-2030)
5.2 Global Insomnia Medication Revenue by Application (2019-2030)
5.2.1 Global Insomnia Medication Revenue by Application (2019-2024)
5.2.2 Global Insomnia Medication Revenue by Application (2025-2030)
5.2.3 Global Insomnia Medication Revenue Market Share by Application (2019-2030)
5.3 Global Insomnia Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eisai
6.1.1 Eisai Corporation Information
6.1.2 Eisai Description and Business Overview
6.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eisai Insomnia Medication Product Portfolio
6.1.5 Eisai Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Insomnia Medication Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Insomnia Medication Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Insomnia Medication Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Insomnia Medication Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Vanda Pharmaceuticals
6.6.1 Vanda Pharmaceuticals Corporation Information
6.6.2 Vanda Pharmaceuticals Description and Business Overview
6.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vanda Pharmaceuticals Insomnia Medication Product Portfolio
6.6.5 Vanda Pharmaceuticals Recent Developments/Updates
6.7 Astellas
6.6.1 Astellas Corporation Information
6.6.2 Astellas Description and Business Overview
6.6.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Insomnia Medication Product Portfolio
6.7.5 Astellas Recent Developments/Updates
6.8 Dainippon Sumitomo
6.8.1 Dainippon Sumitomo Corporation Information
6.8.2 Dainippon Sumitomo Description and Business Overview
6.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dainippon Sumitomo Insomnia Medication Product Portfolio
6.8.5 Dainippon Sumitomo Recent Developments/Updates
6.9 ECR Pharmaceuticals (Valeant)
6.9.1 ECR Pharmaceuticals (Valeant) Corporation Information
6.9.2 ECR Pharmaceuticals (Valeant) Description and Business Overview
6.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio
6.9.5 ECR Pharmaceuticals (Valeant) Recent Developments/Updates
6.10 Flynn Pharma
6.10.1 Flynn Pharma Corporation Information
6.10.2 Flynn Pharma Description and Business Overview
6.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Flynn Pharma Insomnia Medication Product Portfolio
6.10.5 Flynn Pharma Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Insomnia Medication Description and Business Overview
6.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson & Johnson Insomnia Medication Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Meda
6.12.1 Meda Corporation Information
6.12.2 Meda Insomnia Medication Description and Business Overview
6.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Meda Insomnia Medication Product Portfolio
6.12.5 Meda Recent Developments/Updates
6.13 Somnus Therapeutics
6.13.1 Somnus Therapeutics Corporation Information
6.13.2 Somnus Therapeutics Insomnia Medication Description and Business Overview
6.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Somnus Therapeutics Insomnia Medication Product Portfolio
6.13.5 Somnus Therapeutics Recent Developments/Updates
6.14 Purdue Pharma
6.14.1 Purdue Pharma Corporation Information
6.14.2 Purdue Pharma Insomnia Medication Description and Business Overview
6.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Purdue Pharma Insomnia Medication Product Portfolio
6.14.5 Purdue Pharma Recent Developments/Updates
6.15 Neurim
6.15.1 Neurim Corporation Information
6.15.2 Neurim Insomnia Medication Description and Business Overview
6.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Neurim Insomnia Medication Product Portfolio
6.15.5 Neurim Recent Developments/Updates
6.16 Minerva Neurosciences
6.16.1 Minerva Neurosciences Corporation Information
6.16.2 Minerva Neurosciences Insomnia Medication Description and Business Overview
6.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Minerva Neurosciences Insomnia Medication Product Portfolio
6.16.5 Minerva Neurosciences Recent Developments/Updates
6.17 Pernix Therapeutics
6.17.1 Pernix Therapeutics Corporation Information
6.17.2 Pernix Therapeutics Insomnia Medication Description and Business Overview
6.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Pernix Therapeutics Insomnia Medication Product Portfolio
6.17.5 Pernix Therapeutics Recent Developments/Updates
6.18 SkyePharma
6.18.1 SkyePharma Corporation Information
6.18.2 SkyePharma Insomnia Medication Description and Business Overview
6.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.18.4 SkyePharma Insomnia Medication Product Portfolio
6.18.5 SkyePharma Recent Developments/Updates
6.19 Paratek Pharmaceuticals
6.19.1 Paratek Pharmaceuticals Corporation Information
6.19.2 Paratek Pharmaceuticals Insomnia Medication Description and Business Overview
6.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Paratek Pharmaceuticals Insomnia Medication Product Portfolio
6.19.5 Paratek Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insomnia Medication Industry Chain Analysis
7.2 Insomnia Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insomnia Medication Production Mode & Process
7.4 Insomnia Medication Sales and Marketing
7.4.1 Insomnia Medication Sales Channels
7.4.2 Insomnia Medication Distributors
7.5 Insomnia Medication Customers
8 Insomnia Medication Market Dynamics
8.1 Insomnia Medication Industry Trends
8.2 Insomnia Medication Market Drivers
8.3 Insomnia Medication Market Challenges
8.4 Insomnia Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Insomnia Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insomnia Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Insomnia Medication Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insomnia Medication Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Insomnia Medication Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insomnia Medication Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insomnia Medication Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insomnia Medication Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insomnia Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insomnia Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insomnia Medication, Product Type & Application
Table 12. Global Key Manufacturers of Insomnia Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insomnia Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insomnia Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insomnia Medication Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Insomnia Medication Sales Market Share by Region (2019-2024)
Table 19. Global Insomnia Medication Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Insomnia Medication Sales Market Share by Region (2025-2030)
Table 21. Global Insomnia Medication Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insomnia Medication Revenue Market Share by Region (2019-2024)
Table 23. Global Insomnia Medication Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insomnia Medication Revenue Market Share by Region (2025-2030)
Table 25. North America Insomnia Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insomnia Medication Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Insomnia Medication Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Insomnia Medication Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insomnia Medication Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insomnia Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insomnia Medication Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Insomnia Medication Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Insomnia Medication Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insomnia Medication Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insomnia Medication Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insomnia Medication Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Insomnia Medication Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Insomnia Medication Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insomnia Medication Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insomnia Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insomnia Medication Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Insomnia Medication Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Insomnia Medication Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insomnia Medication Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Insomnia Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Insomnia Medication Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Insomnia Medication Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Insomnia Medication Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insomnia Medication Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insomnia Medication Sales (K Pcs) by Type (2019-2024)
Table 51. Global Insomnia Medication Sales (K Pcs) by Type (2025-2030)
Table 52. Global Insomnia Medication Sales Market Share by Type (2019-2024)
Table 53. Global Insomnia Medication Sales Market Share by Type (2025-2030)
Table 54. Global Insomnia Medication Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insomnia Medication Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insomnia Medication Revenue Market Share by Type (2019-2024)
Table 57. Global Insomnia Medication Revenue Market Share by Type (2025-2030)
Table 58. Global Insomnia Medication Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Insomnia Medication Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Insomnia Medication Sales (K Pcs) by Application (2019-2024)
Table 61. Global Insomnia Medication Sales (K Pcs) by Application (2025-2030)
Table 62. Global Insomnia Medication Sales Market Share by Application (2019-2024)
Table 63. Global Insomnia Medication Sales Market Share by Application (2025-2030)
Table 64. Global Insomnia Medication Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insomnia Medication Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insomnia Medication Revenue Market Share by Application (2019-2024)
Table 67. Global Insomnia Medication Revenue Market Share by Application (2025-2030)
Table 68. Global Insomnia Medication Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Insomnia Medication Price (USD/Pcs) by Application (2025-2030)
Table 70. Eisai Corporation Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Eisai Insomnia Medication Product
Table 74. Eisai Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Merck Insomnia Medication Product
Table 79. Merck Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Pfizer Insomnia Medication Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Sanofi Insomnia Medication Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Takeda Insomnia Medication Product
Table 94. Takeda Recent Developments/Updates
Table 95. Vanda Pharmaceuticals Corporation Information
Table 96. Vanda Pharmaceuticals Description and Business Overview
Table 97. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Vanda Pharmaceuticals Insomnia Medication Product
Table 99. Vanda Pharmaceuticals Recent Developments/Updates
Table 100. Astellas Corporation Information
Table 101. Astellas Description and Business Overview
Table 102. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Astellas Insomnia Medication Product
Table 104. Astellas Recent Developments/Updates
Table 105. Dainippon Sumitomo Corporation Information
Table 106. Dainippon Sumitomo Description and Business Overview
Table 107. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Dainippon Sumitomo Insomnia Medication Product
Table 109. Dainippon Sumitomo Recent Developments/Updates
Table 110. ECR Pharmaceuticals (Valeant) Corporation Information
Table 111. ECR Pharmaceuticals (Valeant) Description and Business Overview
Table 112. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. ECR Pharmaceuticals (Valeant) Insomnia Medication Product
Table 114. ECR Pharmaceuticals (Valeant) Recent Developments/Updates
Table 115. Flynn Pharma Corporation Information
Table 116. Flynn Pharma Description and Business Overview
Table 117. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Flynn Pharma Insomnia Medication Product
Table 119. Flynn Pharma Recent Developments/Updates
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Johnson & Johnson Insomnia Medication Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. Meda Corporation Information
Table 126. Meda Description and Business Overview
Table 127. Meda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Meda Insomnia Medication Product
Table 129. Meda Recent Developments/Updates
Table 130. Somnus Therapeutics Corporation Information
Table 131. Somnus Therapeutics Description and Business Overview
Table 132. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. Somnus Therapeutics Insomnia Medication Product
Table 134. Somnus Therapeutics Recent Developments/Updates
Table 135. Purdue Pharma Corporation Information
Table 136. Purdue Pharma Description and Business Overview
Table 137. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 138. Purdue Pharma Insomnia Medication Product
Table 139. Purdue Pharma Recent Developments/Updates
Table 140. Neurim Corporation Information
Table 141. Neurim Description and Business Overview
Table 142. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 143. Neurim Insomnia Medication Product
Table 144. Neurim Recent Developments/Updates
Table 145. Minerva Neurosciences Corporation Information
Table 146. Minerva Neurosciences Description and Business Overview
Table 147. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 148. Minerva Neurosciences Insomnia Medication Product
Table 149. Minerva Neurosciences Recent Developments/Updates
Table 150. Pernix Therapeutics Corporation Information
Table 151. Pernix Therapeutics Description and Business Overview
Table 152. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 153. Pernix Therapeutics Insomnia Medication Product
Table 154. Pernix Therapeutics Recent Developments/Updates
Table 155. SkyePharma Corporation Information
Table 156. SkyePharma Description and Business Overview
Table 157. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 158. SkyePharma Insomnia Medication Product
Table 159. SkyePharma Recent Developments/Updates
Table 160. Paratek Pharmaceuticals Corporation Information
Table 161. Paratek Pharmaceuticals Description and Business Overview
Table 162. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 163. Paratek Pharmaceuticals Insomnia Medication Product
Table 164. Paratek Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Insomnia Medication Distributors List
Table 168. Insomnia Medication Customers List
Table 169. Insomnia Medication Market Trends
Table 170. Insomnia Medication Market Drivers
Table 171. Insomnia Medication Market Challenges
Table 172. Insomnia Medication Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insomnia Medication
Figure 2. Global Insomnia Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insomnia Medication Market Share by Type in 2023 & 2030
Figure 4. Nonbenzodiazepine Receptor Agonists Product Picture
Figure 5. Benzodiazepine Receptor Agonists Product Picture
Figure 6. The Selective Melatonin Receptor Agonist Ramelteon Product Picture
Figure 7. Sedating Antidepressants Product Picture
Figure 8. Global Insomnia Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Insomnia Medication Market Share by Application in 2023 & 2030
Figure 10. Adults
Figure 11. Kids
Figure 12. Global Insomnia Medication Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Insomnia Medication Market Size (2019-2030) & (US$ Million)
Figure 14. Global Insomnia Medication Sales (2019-2030) & (K Pcs)
Figure 15. Global Insomnia Medication Average Price (USD/Pcs) & (2019-2030)
Figure 16. Insomnia Medication Report Years Considered
Figure 17. Insomnia Medication Sales Share by Manufacturers in 2023
Figure 18. Global Insomnia Medication Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Insomnia Medication Players: Market Share by Revenue in 2023
Figure 20. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Insomnia Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Insomnia Medication Sales Market Share by Country (2019-2030)
Figure 23. North America Insomnia Medication Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Insomnia Medication Sales Market Share by Country (2019-2030)
Figure 27. Europe Insomnia Medication Revenue Market Share by Country (2019-2030)
Figure 28. Germany Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Insomnia Medication Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Insomnia Medication Revenue Market Share by Region (2019-2030)
Figure 35. China Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Insomnia Medication Sales Market Share by Country (2019-2030)
Figure 45. Latin America Insomnia Medication Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Insomnia Medication Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Insomnia Medication Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Insomnia Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Insomnia Medication by Type (2019-2030)
Figure 55. Global Revenue Market Share of Insomnia Medication by Type (2019-2030)
Figure 56. Global Insomnia Medication Price (USD/Pcs) by Type (2019-2030)
Figure 57. Global Sales Market Share of Insomnia Medication by Application (2019-2030)
Figure 58. Global Revenue Market Share of Insomnia Medication by Application (2019-2030)
Figure 59. Global Insomnia Medication Price (USD/Pcs) by Application (2019-2030)
Figure 60. Insomnia Medication Value Chain
Figure 61. Insomnia Medication Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock